Imageable biopsy site marker
Abstract
A biopsy site marker having at least one small marker body or pellet of bioresorbable material such as gelatin, collagen, polylactic acid, polyglycolic acid which has a radiopaque object, preferably with a non-biological configuration. The at least one bioresorbable body or pellet with a radiopaque object is deposited into the biopsy site, by a delivery device that includes an elongated tubular body with a piston slidable within the tubular body. One end of the tube is placed into the biopsy site. At least one but preferably several marker bodies or pellets are deposited sequentially into the biopsy site through the tube. At least the bioresorbable materials of the detectable markers remain present in sufficient quantity to permit detection and location of the biopsy site at a first time point (e.g., 2 weeks) after introduction but clear from the biopsy site or otherwise do not interfere with imaging of tissues adjacent the biopsy site at a second time point (e.g., 5-7 months) after introduction.
Claims
exact text as granted — not AI-modified1 - 17 . (canceled)
18 . A device for marking a biopsy cavity site comprising:
an implantable medical device comprising
a proximal end;
a distal end;
a lumen disposed between the proximal end and the distal end; and
a piece disposed within the lumen,
wherein the piece comprises a component that is configured to generate and emit a first signal after receiving a second signal requesting that the component generate and emit the first signal when deployed at the biopsy cavity site thereby marking the biopsy cavity site.
19 . The device of claim 18 wherein the component is adapted to emit a detectable first signal that comprises a radiofrequency signal or an ultrasound signal after the component receives the second signal.
20 . The device of claim 19 wherein the second signal comprises an ultrasound signal.
21 . The device of claim 20 wherein the component comprises a transmitter.
22 . The device of claim 20 wherein the component comprises an ultrasound transducer.
23 . The device of claim 19 wherein the second signal comprises a radiofrequency signal.
24 . The device of claim 23 wherein the component comprises a transmitter.
25 . The device of claim 23 wherein the component comprises an ultrasound transducer.
26 . A method, comprising:
providing a target tissue localization device for marking a biopsy cavity site comprising:
a proximal end;
a distal end;
a discharge opening at or near the distal end;
a lumen disposed between the proximal end and the distal end extending to and in fluid communication with the discharge opening;
a piece disposed within the lumen,
wherein the piece comprises a component that is configured to generate and emit a first signal after receiving a second signal requesting that the component generate and emit the first signal when deployed at the biopsy cavity site thereby marking the biopsy cavity site;
removing a biopsy specimen from a breast of a patient, thereby creating the biopsy cavity site; inserting the piece into the biopsy cavity site; generating a second signal; and receiving the first signal indicating the biopsy cavity site.
27 . The method of claim 26 wherein the component is adapted to emit a detectable first signal that comprises a radiofrequency signal or an ultrasound signal after the component receives the second signal.
28 . The method of claim 27 wherein the second signal comprises an ultrasound signal.
29 . The method of claim 28 wherein the component comprises a transmitter.
30 . The method of claim 28 wherein the component comprises an ultrasound transducer.
31 . The method of claim 27 wherein the second signal comprises a radiofrequency signal.
32 . The method of claim 31 wherein the component comprises a transmitter.
33 . The method of claim 31 wherein the component comprises an ultrasound transducer.Join the waitlist — get patent alerts
Track US2016128797A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.